Records containing: Obesity
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-31Integrated Analysis of the Interactions Between Glycemia and Microbiota Composition, and Their Impact on Brain Iron Deposition and Cognition in Subjects With Obesity
-
CLINICAL_TRIALS study record update · 2026-03-31A Prospective Consortium Evaluating the Long-term Follow-up of Patients With Type 2 Diabetes Enrolled In a Randomized Controlled Trial Comparing Bariatric Surgery Versus Medical Management
-
CLINICAL_TRIALS study record update · 2026-03-31Involvement of the Gut Microbiota-brain Cross-talk in the Loss of Eating Control (GMBCrossTalkFood)
-
CLINICAL_TRIALS study record update · 2026-03-30A Randomized Trial of Behaviorally Designed Gamification and Social Incentives to Increase Physical Activity Among Overweight and Obese Veterans
-
CLINICAL_TRIALS study record update · 2026-03-30A Phase I, Single-center, Open-Label, Single-Arm, Fixed-Sequence Study to Evaluate the Influence of HDM1005 on Gastric Emptying and Drug-Drug Interaction of HDM1005 and Metformin, Atorvastatin, Warfarin, and Digoxin in Overweight/Obese Adult Chinese Subjects
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-30Identifying Risk for Diabetes and Heart Disease in Women: A Study of African-American, African and White Federal Employees and Contractors
-
CLINICAL_TRIALS study record update · 2026-03-30Efficacy and Safety of Cagrilintide s.c. 2.4 Milligram (mg) in Combination With Semaglutide Subcutaneous (s.c). 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) Once-weekly in Participants With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2026-03-30A Pilot Study to Determine Tolerability to Glucagon Infusion in Obese Subjects
-
CLINICAL_TRIALS study record update · 2026-03-30Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation in Both Skeletal Muscle and Adipose Tissue
-
CLINICAL_TRIALS study record update · 2026-03-30Examining the Utility of GLP-1 Agonists as Neuroprotective Agents Through a Pilot Clinical Trial in High Risk Population With Neurocognitive Deficits and Obesity
-
CLINICAL_TRIALS study record update · 2026-03-30Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
-
CLINICAL_TRIALS study record update · 2026-03-30Efficacy and Safety of Cagrilintide s.c. in Combination With Semaglutide s.c.(CagriSema s.c. 1.0 mg/1.0 mg and 1.7 mg/1.7 mg) Once-weekly in Participants With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2026-03-30Effect of Body Vibration Sessions on Energy Expenditure at Rest and on Cardiovascular and Musculoskeletal Parameters in Obese Boys Hospitalized for a Multidisciplinary Program of Integrated Metabolic Rehabilitation
-
CLINICAL_TRIALS study record update · 2026-03-27Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure (UNLOAD-Heart Failure)
-
CLINICAL_TRIALS study record update · 2026-03-27MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease: Effects Of Semaglutide Treatment
-
CLINICAL_TRIALS study record update · 2026-03-27A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity
-
CLINICAL_TRIALS study record update · 2026-03-27Prospective Single-center Diagnostic Parallel-group Study to Determine the Minimal Dose of Indocyanine Green to Observe Vascular Perfussion in Revisional Bariatric Surgery.
-
CLINICAL_TRIALS study record update · 2026-03-27Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise
-
CLINICAL_TRIALS study record update · 2026-03-27Remission of Diabetes With Lifestyle Intervention for Malaysian Type 2 Diabetes Mellitus Patients (ReDiaL-MY) - an Open Label, Randomised Controlled Study
-
CLINICAL_TRIALS study record update · 2026-03-27A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of VCT220 Tablets in Overweight or Obese Participants
-
CLINICAL_TRIALS study record update · 2026-03-27Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery
-
CLINICAL_TRIALS study record update · 2026-03-27Effects of Two Different Exercise Programs Combined With the Mediterranean Diet on Inflammatory Status in Subjects With Obesity and NAFLD
-
CLINICAL_TRIALS study record update · 2026-03-27Metabolic Impact on the Mitochondria-gut Microbiota Axis of Failure to Follow Restrictive Dietary Interventions in Subjects Living With Obesity
-
CLINICAL_TRIALS study record update · 2026-03-27The Investigation of the Effects of Functional Inspiratory Muscle Training in Obese Individuals
-
CLINICAL_TRIALS study record update · 2026-03-27Epigenetic Regulation of Human Adipose Tissue Distribution